These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23403711)

  • 1. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
    Morgenweck CJ
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
    Pilkington BC
    J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical considerations for turning off pacemakers and defibrillators.
    Karches KE; Sulmasy DP
    Card Electrophysiol Clin; 2015 Sep; 7(3):547-55. PubMed ID: 26304534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Mitchell SL; Brock DW
    Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pacemaker deactivation: withdrawal of support or active ending of life?
    Huddle TS; Amos Bailey F
    Theor Med Bioeth; 2012 Dec; 33(6):421-33. PubMed ID: 22351107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of cardiac electrical implantable devices in patients nearing the end of life or requesting withdrawal of therapy: review of the Heart Rhythm Society 2010 consensus statement.
    Kramer DB; Ottenberg AL; Mueller PS
    Pol Arch Med Wewn; 2010 Dec; 120(12):497-502. PubMed ID: 21178906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
    Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
    Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivating implantable cardioverter defibrillators.
    Ross HM
    Ann Intern Med; 2005 Nov; 143(9):690; author reply 691. PubMed ID: 16263895
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.
    Kramer DB; Kesselheim AS; Brock DW; Maisel WH
    Heart Rhythm; 2010 Nov; 7(11):1537-42. PubMed ID: 20650332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Ottenberg AL; Gerhardson S; Mueller LA; Kaufman SR; Koenig BA; Mueller PS
    J Interv Card Electrophysiol; 2011 Dec; 32(3):243-52. PubMed ID: 21805140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deactivating implantable cardioverter defibrillators.
    Lynn J
    Ann Intern Med; 2005 Nov; 143(9):691; author reply 691. PubMed ID: 16263897
    [No Abstract]   [Full Text] [Related]  

  • 14. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 15. [Deactivation of implantable defibrillators--also an ethical issue. Written routines of the process are necessary as illustrated by the described case report].
    Carlsson J; Mansson A; Olsson D
    Lakartidningen; 2011 Mar 9-15; 108(10):536-9. PubMed ID: 21744554
    [No Abstract]   [Full Text] [Related]  

  • 16. The ethics of pacemaker deactivation in terminally ill patients.
    Bevins MB
    J Pain Symptom Manage; 2011 Jun; 41(6):1106-10. PubMed ID: 21621131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical dilemmas in device treatment for advanced heart failure.
    Kirkpatrick JN; Fedson SE; Verdino R
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):267-73. PubMed ID: 18685373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
    Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
    Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of deactivating implanted cardioverter defibrillators.
    Berger JT
    Ann Intern Med; 2005 Apr; 142(8):631-4. PubMed ID: 15838070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
    Daeschler M; Verdino RJ; Kirkpatrick JN
    Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.